BioAge Labs, Inc. BIOA
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -55.63%
- 1 year
- -24.06%
- Open
- 5.86
- Prev close
- 5.94
- Mkt cap
- 269.41M
- Vol
- 801.36K
- Avg vol
- 964.44K
- EPS
- -2.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.63
- High
- 5.93
- Forward P/E
- -12.08
- Beta
- 0.00
- Short ratio
- 4.63
- Inst. own
- 85.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 18.87
- 200-d avg
- 15.13
- 1y target
- 49.50
Discussion (3)
Sign in to join the discussion
$BIOA This will close at $10 on Monday. Then it will creep back up slowly but surely to $12-15 (Might take a fee months) Big money will buy for long term prospects of Azelaprag. This oral drug does not just help with weight loss there are other uses for it. It treats neuroinflamation and helps with longevity in metabolic aging especially with older individuals and I need not remind you people are living a lot longer than before. Also the drug by itself restores body composition and muscle function. Its like driving a car you dont just look right in front of you. You should look at the road ahead.
$BIOA Clearly at this price this is going to be a takeover candidate for one of the big players within the next few months. Prudent investors will average down on Monday.
$BIOA JUST A BUMP IN THE ROAD
That was only 1 of 3 on going trials. Along with the 360 Mill of cash on hand and other things in the pipeline we should be fine. Probably a good time to load up while it’s so cheap. Should be back to $20 mid 2025